Where to Give a Buttocks Injection: A Location Guide

The safest spot for a buttocks injection is the ventrogluteal site, located on the upper side of the hip rather than the traditional upper outer quadrant of the rear that most people picture. A cadaver study found the ventrogluteal region sits roughly twice as far from major nerves and blood vessels compared to the classic dorsogluteal site most of us grew up associating with “getting a shot in the butt.”¹ Yet despite decades of clinical evidence, the older location remains stubbornly popular among healthcare providers, and many people who self-inject never learn the safer alternative.

Two Sites, Very Different Risk Profiles

When someone says “buttocks injection,” they could mean one of two places. The dorsogluteal site is the classic spot: the fleshy upper outer area of the buttock cheek, roughly behind and below the hip bone. The ventrogluteal site is on the side of the hip, over the gluteus medius and minimus muscles, forward and slightly above the dorsogluteal zone. These two locations are only a hand’s width apart, but the anatomy underneath them is dramatically different.

The dorsogluteal area is crowded. The sciatic nerve, the largest nerve in the body, passes through this region. So does the superior gluteal artery. In cadaver measurements, the distance from a dorsogluteal needle to the superior gluteal artery averaged under 7 mm, while a ventrogluteal needle sat nearly 14 mm away from the same artery.¹ Those few extra millimeters matter when a sharp needle is involved. The ventrogluteal site also has thicker muscle and thinner fat in most people, which means the medication is more likely to land in muscle tissue where it belongs rather than in the subcutaneous fat layer above it.

A systematic review and meta-analysis pooling data from multiple trials confirmed what the anatomy predicts: injections given at the ventrogluteal site produced significantly less pain, less bleeding, and smaller hematomas compared with dorsogluteal injections.² That pattern held across different medications and different patient populations.

How to Find the Ventrogluteal Site

The ventrogluteal site is located using bony landmarks on the hip, which makes it more precise than the “upper outer quadrant” guesswork used for dorsogluteal injections. The most commonly taught method works like this: place the heel of your hand on the greater trochanter (the bony knob you can feel at the side of the hip when you press inward). Point your index finger toward the front of the hip bone (the anterior superior iliac spine) and spread your middle finger back toward the iliac crest. The injection goes into the V-shaped triangle formed between those two fingers. Research has confirmed this anatomical triangle consistently overlies the gluteus medius muscle with no major nerves or blood vessels underneath.¹

For the person receiving the injection, the ventrogluteal site feels like the side of the hip, not the buttock proper. If you are giving yourself a shot, you would inject into the side of your hip while standing or lying on your side, not into the back of your rear end. This often surprises people who expect a buttocks injection to go where they cannot easily see or reach, but the side-of-hip location is actually more accessible for self-administration because you can see the injection site and use your opposite hand to palpate landmarks.

Why the Dorsogluteal Site Persists

If the ventrogluteal site is safer, less painful, and better supported by evidence, why do most nurses still default to the dorsogluteal? Surveys consistently find the older site dominates clinical practice. One study reported that over 62% of nurses preferred the dorsogluteal site, while only about 5% preferred the ventrogluteal.³ The reasons nurses gave for sticking with the dorsogluteal site included habit, the belief it was the site they were trained on, and patient expectations. A separate survey found that site selection varied with a nurse’s age, education level, and years of experience, with many nurses unaware that nerve injury was a risk at their chosen site.⁴

Among nursing students, the picture is not much better. When asked to mark an injection site on a diagram, about a third of students chose a location outside the safe upper outer quadrant of the dorsogluteal region, and roughly half of those who did mark the correct quadrant could not correctly explain the anatomical reason for choosing it.⁵ This suggests the problem is partly educational: many clinicians are never properly taught the ventrogluteal technique, and those who learn the dorsogluteal site often learn it imprecisely.

What Can Go Wrong at the Dorsogluteal Site

The most feared complication is sciatic nerve injury. Symptoms can range from brief, sharp pain radiating down the leg to permanent nerve damage with foot drop, muscle weakness, and chronic neuropathic pain that resists treatment.⁶ In one documented case, a 68-year-old man developed intractable nerve pain after a routine analgesic injection into the dorsogluteal site; despite surgical intervention months later, the pain only partially improved.⁷ MR imaging studies of injection-related sciatic injuries have shown that damage tends to concentrate in the peroneal division of the nerve, which controls the muscles that lift the foot. While some patients recover fully, others are left with permanent deficits.⁸

Nerve damage is not the only risk. A needle that strays into or near the superior gluteal artery can cause bleeding deep in the muscle. One case report described how such bleeding created a hematoma that became a deep abscess, progressing toward a pre-septic state that required emergency treatment.⁹ Another underappreciated complication is the injection granuloma, a lumpy inflammatory reaction that forms when medication lands in the fat layer instead of the muscle. These granulomas can grow large enough to mimic soft tissue tumors on imaging, sometimes prompting unnecessary biopsies or surgery.¹⁰ The buttock’s thicker subcutaneous fat layer, especially in women, makes unintentional subcutaneous delivery more common than at other injection sites.¹¹

Legal Consequences of Injection Injuries

Injection-related nerve injuries are not just a clinical concern; they generate real legal liability. An analysis of Supreme Court decisions in Turkey found that gluteal injections accounted for 79% of all injection-injury lawsuits reviewed. Nurses were the providers in 60% of the cases, and the most common scenarios involved postoperative pain relief or antibiotic therapy. In over three-quarters of cases, symptoms appeared immediately or within one hour of the injection, and nerve studies typically revealed severe damage to the peroneal division of the sciatic nerve.¹² Missing informed-consent documentation and contradictory expert reports were among the reasons higher courts overturned lower-court rulings, highlighting how thoroughly these cases get scrutinized.

Needle Length and Body Size

Choosing the right injection site is only half the equation. If the needle is too short to reach the muscle, the medication ends up in the fat layer, where absorption is slower and complications like granulomas become more likely. How much fat sits between the skin and the muscle varies enormously depending on a person’s body composition and sex.

Research on the ventrogluteal site found a strong correlation between body mass index and the thickness of subcutaneous fat. For women, the standard 1.5-inch (3.75 cm) needle failed to reach muscle tissue in roughly 71% of cases when BMI exceeded 30, and for men, the failure rate hit about 60% above a BMI of 35.¹³ A systematic review confirmed that women generally carry thicker subcutaneous tissue at the ventrogluteal site than men do.¹⁴ For people with higher BMI, a longer needle or an alternative site like the vastus lateralis (outer thigh) may be more appropriate. This is a conversation worth having with a healthcare provider, because the wrong needle length effectively turns what should be an intramuscular injection into a subcutaneous one, changing both how the drug works and what side effects you might experience.

The Ventrogluteal Site in Older Adults

Age-related changes in body composition raise questions about whether the standard sites remain safe for older adults. An ultrasound-based study specifically examining older adults found that both the ventrogluteal and dorsogluteal sites met published safety thresholds for intramuscular injection. However, the ventrogluteal site offered thicker muscle (about 40 mm versus 26 mm) and thinner subcutaneous tissue (about 20 mm versus 23 mm), making it safer in terms of both reaching the muscle and avoiding bone contact.¹⁵ For older adults who may have lost muscle mass in certain areas, the ventrogluteal site’s relatively preserved thickness is an advantage.

Injections in Children

In young children, the vastus lateralis (outer thigh) has long been the default intramuscular injection site because the gluteal muscles were assumed to be underdeveloped. Research has challenged that assumption. A study of children aged 1 to 36 months found that the muscle at the ventrogluteal site was adequately developed even in infants between 1 and 12 months, and in children 12 to 36 months old, the ventrogluteal muscle layer was thicker than the anterolateral thigh.¹⁶ Additional measurements in 642 children aged 2 to 18 months confirmed that the ventrogluteal site is a viable option for vaccinations in infants and toddlers.¹⁷ The thigh remains the most commonly recommended site for very young children in current vaccination guidelines, but the ventrogluteal area is increasingly recognized as a safe alternative when clinicians are comfortable with the landmark technique in small bodies.

Technique Tips That Reduce Pain and Complications

Regardless of which site you use, how you give the injection matters. The Z-track technique, where you pull the skin to one side before inserting the needle and release it afterward so the skin and muscle layers no longer line up, creates a zigzag path that seals medication inside the muscle and prevents it from leaking back through the needle track. A randomized controlled trial found that the Z-track method produced significantly less pain, less drug leakage, and less inflammation at the injection site compared to the standard technique.¹⁸

Patient positioning also plays a role. A crossover study comparing ventrogluteal injections given while standing versus lying down found that standing produced lower pain scores on average. The mean pain score was about 1.1 on a visual analog scale when standing, compared to about 1.9 when lying down, and participants were nearly four times more likely to report lower pain in the standing position.¹⁹ Standing may help because the gluteal muscles are more relaxed when weight is shifted to the opposite leg, making needle insertion easier and less painful. For dorsogluteal injections, the traditional advice is to have the person lie face down with toes pointed inward to relax the muscle, but even optimal positioning at that site does not eliminate the underlying anatomical risks.

Ultrasound-Guided Injection

In some clinical settings, ultrasound imaging is used to confirm the injection site before or during needle insertion. An ultrasound device can show the exact thickness of the subcutaneous and muscle layers, the location of blood vessels, the depth of the needle in real time, and how medication is distributing once injected.²⁰ This is not practical for routine vaccinations or most standard injections, but it has clear value in research settings, for patients with unusual anatomy, or in cases where repeated injections need to be placed precisely. Portable ultrasound units have become much cheaper and smaller, which may make this approach more accessible in the future.

Self-Injection Considerations

Many people give themselves intramuscular injections at home for testosterone therapy, fertility treatments, vitamin B12, or other medications. If you are self-injecting into the gluteal area, the ventrogluteal site is not just safer but also more practical. Because it sits on the side of the hip rather than the back of the buttock, you can see it, reach it comfortably, and palpate the bony landmarks with your free hand. The dorsogluteal site is harder to see and harder to reach accurately without twisting, which increases the chance of placing the needle in the wrong spot.

Before self-injecting, it is worth confirming that the needle length is appropriate for your body size. As described earlier, the standard 1.5-inch needle does not reliably reach muscle in people with higher BMI, and the subcutaneous fat layer at the gluteal region tends to be thicker in women than in men. Your prescriber or pharmacist can help you select the correct gauge and length. Some people find the outer thigh (vastus lateralis) easier for self-injection because it is fully visible and does not require any body rotation, which is worth discussing if you find the ventrogluteal site awkward.

For medications that cause significant irritation, using the Z-track technique at home is straightforward once you learn it. Pull the skin at the injection site firmly to one side with your non-dominant hand, insert the needle, inject slowly, wait a few seconds, withdraw the needle, and then release the skin. The displaced tissue layers seal the track and reduce both leakage and local irritation. Applying firm pressure with a cotton ball afterward, rather than rubbing, also helps minimize bruising.

When the Dorsogluteal Site Is Still Used

Despite its disadvantages, the dorsogluteal site has not disappeared from practice entirely, and there are a few scenarios where clinicians may still use it. Some medications with large volumes or oily formulations (certain long-acting antipsychotics, for example) are specifically labeled for dorsogluteal administration based on the trials that earned their approval. In those cases, the prescribing information may direct use of that site. Very thin patients with minimal lateral hip muscle mass may also present situations where the dorsogluteal region offers more tissue depth, though this is uncommon. And in emergency or field settings where a patient cannot be repositioned and the side of the hip is inaccessible, a dorsogluteal injection may be the only realistic option.

If the dorsogluteal site must be used, proper landmarking becomes critical. The traditional “upper outer quadrant” method, where you mentally divide the buttock into four squares and aim for the top outer one, is imprecise and accounts for many misplaced injections. A more reliable approach uses the posterior superior iliac spine and the greater trochanter as landmarks to draw an imaginary line, then injecting above and lateral to that line. Even so, the evidence is clear that whenever the ventrogluteal site is accessible, it is the better choice in terms of distance from nerves, distance from major blood vessels, muscle depth, pain levels, and complication rates.